Global Neglected Tropical Diseases Drugs and Vaccine Market Research Report 2025(Status and Outlook)
Report Overview
Neglected tropical diseases (NTDs) are a diverse group of tropical infections which are common in low-income populations in developing regions of Africa, Asia, and the Americas. They are caused by a variety of pathogens such as viruses, bacteria, protozoa and helminths.
This report provides a deep insight into the global Neglected Tropical Diseases Drugs and Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Neglected Tropical Diseases Drugs and Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Neglected Tropical Diseases Drugs and Vaccine market in any manner.
Global Neglected Tropical Diseases Drugs and Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Artecef BV
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi-Aventis
Ranbaxy Labs
Lupin
Macleods Pharmaceuticals
Cipla
Romark Laboratories
Toyama Chemica
Market Segmentation (by Type)
Malaria
Ebola
Dengue
Chagas
Leishmaniasis
Other
Market Segmentation (by Application)
Drugs
Vaccines
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Neglected Tropical Diseases Drugs and Vaccine Market
- Overview of the regional outlook of the Neglected Tropical Diseases Drugs and Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neglected Tropical Diseases Drugs and Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Neglected Tropical Diseases Drugs and Vaccine
1.2 Key Market Segments
1.2.1 Neglected Tropical Diseases Drugs and Vaccine Segment by Type
1.2.2 Neglected Tropical Diseases Drugs and Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Product Life Cycle
3.3 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neglected Tropical Diseases Drugs and Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Neglected Tropical Diseases Drugs and Vaccine Manufacturing Sites, Area Served, Product Type
3.8 Neglected Tropical Diseases Drugs and Vaccine Market Competitive Situation and Trends
3.8.1 Neglected Tropical Diseases Drugs and Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Neglected Tropical Diseases Drugs and Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Neglected Tropical Diseases Drugs and Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Neglected Tropical Diseases Drugs and Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Neglected Tropical Diseases Drugs and Vaccine Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET BY REGION
6.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
6.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
6.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Region
6.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region
6.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region
6.2.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
7.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
8.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
9.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
10.3 South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
11.3 Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
12 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET PRODUCTION BY REGION
12.1 Global Production of Neglected Tropical Diseases Drugs and Vaccine by Region(2020-2025)
12.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Region (2020-2025)
12.3 Global Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Neglected Tropical Diseases Drugs and Vaccine Production
12.4.1 North America Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2020-2025)
12.4.2 North America Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Neglected Tropical Diseases Drugs and Vaccine Production
12.5.1 Europe Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2020-2025)
12.5.2 Europe Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Neglected Tropical Diseases Drugs and Vaccine Production (2020-2025)
12.6.1 Japan Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2020-2025)
12.6.2 Japan Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Neglected Tropical Diseases Drugs and Vaccine Production (2020-2025)
12.7.1 China Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2020-2025)
12.7.2 China Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
13 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Type (2020-2033)
13.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2020-2033)
13.4 Global Neglected Tropical Diseases Drugs and Vaccine Price by Type (2020-2033)
14 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Sales by Application (2020-2033)
14.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2020-2033)
14.4 Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 Artecef BV
15.1.1 Artecef BV Basic Information
15.1.2 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.1.4 Artecef BV Business Overview
15.1.5 Artecef BV SWOT Analysis
15.1.6 Artecef BV Recent Developments
15.2 GlaxoSmithKline
15.2.1 GlaxoSmithKline Basic Information
15.2.2 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.2.4 GlaxoSmithKline Business Overview
15.2.5 GlaxoSmithKline SWOT Analysis
15.2.6 GlaxoSmithKline Recent Developments
15.3 AstraZeneca
15.3.1 AstraZeneca Basic Information
15.3.2 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.3.4 AstraZeneca Business Overview
15.3.5 AstraZeneca SWOT Analysis
15.3.6 AstraZeneca Recent Developments
15.4 Novartis
15.4.1 Novartis Basic Information
15.4.2 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.4.4 Novartis Business Overview
15.4.5 Novartis Recent Developments
15.5 Sanofi-Aventis
15.5.1 Sanofi-Aventis Basic Information
15.5.2 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.5.4 Sanofi-Aventis Business Overview
15.5.5 Sanofi-Aventis Recent Developments
15.6 Ranbaxy Labs
15.6.1 Ranbaxy Labs Basic Information
15.6.2 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.6.4 Ranbaxy Labs Business Overview
15.6.5 Ranbaxy Labs Recent Developments
15.7 Lupin
15.7.1 Lupin Basic Information
15.7.2 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.7.4 Lupin Business Overview
15.7.5 Lupin Recent Developments
15.8 Macleods Pharmaceuticals
15.8.1 Macleods Pharmaceuticals Basic Information
15.8.2 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.8.4 Macleods Pharmaceuticals Business Overview
15.8.5 Macleods Pharmaceuticals Recent Developments
15.9 Cipla
15.9.1 Cipla Basic Information
15.9.2 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.9.4 Cipla Business Overview
15.9.5 Cipla Recent Developments
15.10 Romark Laboratories
15.10.1 Romark Laboratories Basic Information
15.10.2 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.10.4 Romark Laboratories Business Overview
15.10.5 Romark Laboratories Recent Developments
15.11 Toyama Chemica
15.11.1 Toyama Chemica Basic Information
15.11.2 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.11.4 Toyama Chemica Business Overview
15.11.5 Toyama Chemica Recent Developments
16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 4. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (M USD)
Table 5. Neglected Tropical Diseases Drugs and Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2024)
Table 11. Global Market Neglected Tropical Diseases Drugs and Vaccine Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Neglected Tropical Diseases Drugs and Vaccine Manufacturing Sites and Area Served
Table 13. Manufacturers Neglected Tropical Diseases Drugs and Vaccine Product Type
Table 14. Global Neglected Tropical Diseases Drugs and Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neglected Tropical Diseases Drugs and Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Neglected Tropical Diseases Drugs and Vaccine Market Size Comparison by Region (M USD)
Table 26. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2020-2033) & (M USD)
Table 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Region (2020-2033)
Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region (2020-2033) & (K MT)
Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region (2020-2033)
Table 30. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2033) & (M USD)
Table 31. North America Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2020-2033) & (K MT)
Table 32. North America Neglected Tropical Diseases Drugs and Vaccine Sales by Type (K MT)
Table 33. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 34. North America Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Type (2020-2033)
Table 35. North America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type (2020-2033)
Table 36. North America Neglected Tropical Diseases Drugs and Vaccine Sales by Application (K MT)
Table 37. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (M USD)
Table 38. North America Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Application (2020-2033)
Table 39. North America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2020-2033)
Table 40. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2020-2033) & (K MT)
Table 42. Europe Neglected Tropical Diseases Drugs and Vaccine Sales by Type (K MT)
Table 43. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 44. Europe Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Type (2020-2033)
Table 45. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type (2020-2033)
Table 46. Europe Neglected Tropical Diseases Drugs and Vaccine Sales by Application (K MT)
Table 47. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (M USD)
Table 48. Europe Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Application (2020-2033)
Table 49. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Sales by Type (K MT)
Table 53. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 54. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Sales by Application (K MT)
Table 57. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (M USD)
Table 58. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2020-2025)
Table 60. South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2033) & (M USD)
Table 61. South America Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2020-2033) & (K MT)
Table 62. South America Neglected Tropical Diseases Drugs and Vaccine Sales by Type (K MT)
Table 63. South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 64. South America Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Type (2020-2033)
Table 65. South America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type (2020-2033)
Table 66. South America Neglected Tropical Diseases Drugs and Vaccine Sales by Application (K MT)
Table 67. South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (M USD)
Table 68. South America Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Application (2020-2033)
Table 69. South America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales by Type (K MT)
Table 73. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 74. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales by Application (K MT)
Table 77. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (M USD)
Table 78. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2020-2033)
Table 80. Global Neglected Tropical Diseases Drugs and Vaccine Production (K MT) by Region(2020-2025)
Table 81. Global Neglected Tropical Diseases Drugs and Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Region (2020-2025)
Table 83. Global Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Type (K MT)
Table 89. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 90. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Type (2020-2033)
Table 91. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Type (2020-2033)
Table 92. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type (2020-2033)
Table 93. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Share by Type (2020-2033)
Table 94. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Application
Table 95. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application(M USD)
Table 96. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Application (2020-2033) & (K MT)
Table 97. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application (2020-2033)
Table 98. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2020-2033) & (M USD)
Table 99. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2020-2033)
Table 100. Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2020-2033)
Table 101. Artecef BV Basic Information
Table 102. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 103. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Artecef BV Business Overview
Table 105. Artecef BV SWOT Analysis
Table 106. Artecef BV Recent Developments
Table 107. GlaxoSmithKline Basic Information
Table 108. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 109. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. GlaxoSmithKline Business Overview
Table 111. GlaxoSmithKline SWOT Analysis
Table 112. GlaxoSmithKline Recent Developments
Table 113. AstraZeneca Basic Information
Table 114. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 115. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. AstraZeneca Business Overview
Table 117. AstraZeneca SWOT Analysis
Table 118. AstraZeneca Recent Developments
Table 119. Novartis Basic Information
Table 120. Novartis Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 121. Novartis Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Novartis Business Overview
Table 123. Novartis Recent Developments
Table 124. Sanofi-Aventis Basic Information
Table 125. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 126. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Sanofi-Aventis Business Overview
Table 128. Sanofi-Aventis Recent Developments
Table 129. Ranbaxy Labs Basic Information
Table 130. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 131. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Ranbaxy Labs Business Overview
Table 133. Ranbaxy Labs Recent Developments
Table 134. Lupin Basic Information
Table 135. Lupin Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 136. Lupin Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Lupin Business Overview
Table 138. Lupin Recent Developments
Table 139. Macleods Pharmaceuticals Basic Information
Table 140. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 141. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Macleods Pharmaceuticals Business Overview
Table 143. Macleods Pharmaceuticals Recent Developments
Table 144. Cipla Basic Information
Table 145. Cipla Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 146. Cipla Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Cipla Business Overview
Table 148. Cipla Recent Developments
Table 149. Romark Laboratories Basic Information
Table 150. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 151. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Romark Laboratories Business Overview
Table 153. Romark Laboratories Recent Developments
Table 154. Toyama Chemica Basic Information
Table 155. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 156. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Toyama Chemica Business Overview
Table 158. Toyama Chemica Recent Developments
List of Figures
Figure 1. Product Picture of Neglected Tropical Diseases Drugs and Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neglected Tropical Diseases Drugs and Vaccine Product Life Cycle
Figure 13. Neglected Tropical Diseases Drugs and Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Neglected Tropical Diseases Drugs and Vaccine Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Neglected Tropical Diseases Drugs and Vaccine
Figure 19. Global Neglected Tropical Diseases Drugs and Vaccine Market PEST Analysis
Figure 20. Global Neglected Tropical Diseases Drugs and Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
Figure 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Region (2020-2033)
Figure 28. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Country
Figure 33. USA Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Neglected Tropical Diseases Drugs and Vaccine Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD)by Type
Figure 40. North America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Country
Figure 45. Germany Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type
Figure 56. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Country
Figure 61. China Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type
Figure 72. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Country
Figure 77. Brazil Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type
Figure 84. South America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Country
Figure 89. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type
Figure 100. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application
Figure 101. Global Neglected Tropical Diseases Drugs and Vaccine Production Market Share by Region (2020-2025)
Figure 102. North America Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. China Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Figure 108. Sales Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type (2020-2033)
Figure 109. Sales Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type in 2024
Figure 110. Market Size Share of Neglected Tropical Diseases Drugs and Vaccine by Type (2020-2033)
Figure 111. Market Size Share of Neglected Tropical Diseases Drugs and Vaccine by Type in 2024
Figure 112. Global Neglected Tropical Diseases Drugs and Vaccine Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application(M USD)
Figure 115. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application
Figure 116. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application (2020-2033)
Figure 117. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application in 2024
Figure 118. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2020-2033)
Figure 119. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application in 2024
Figure 120. Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2020-2033)
1.1 Market Definition and Statistical Scope of Neglected Tropical Diseases Drugs and Vaccine
1.2 Key Market Segments
1.2.1 Neglected Tropical Diseases Drugs and Vaccine Segment by Type
1.2.2 Neglected Tropical Diseases Drugs and Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Product Life Cycle
3.3 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neglected Tropical Diseases Drugs and Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Neglected Tropical Diseases Drugs and Vaccine Manufacturing Sites, Area Served, Product Type
3.8 Neglected Tropical Diseases Drugs and Vaccine Market Competitive Situation and Trends
3.8.1 Neglected Tropical Diseases Drugs and Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Neglected Tropical Diseases Drugs and Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Neglected Tropical Diseases Drugs and Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Neglected Tropical Diseases Drugs and Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Neglected Tropical Diseases Drugs and Vaccine Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET BY REGION
6.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
6.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
6.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Region
6.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region
6.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region
6.2.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
7.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
8.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
9.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
10.3 South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type
11.3 Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application
12 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET PRODUCTION BY REGION
12.1 Global Production of Neglected Tropical Diseases Drugs and Vaccine by Region(2020-2025)
12.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Region (2020-2025)
12.3 Global Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Neglected Tropical Diseases Drugs and Vaccine Production
12.4.1 North America Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2020-2025)
12.4.2 North America Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Neglected Tropical Diseases Drugs and Vaccine Production
12.5.1 Europe Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2020-2025)
12.5.2 Europe Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Neglected Tropical Diseases Drugs and Vaccine Production (2020-2025)
12.6.1 Japan Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2020-2025)
12.6.2 Japan Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Neglected Tropical Diseases Drugs and Vaccine Production (2020-2025)
12.7.1 China Neglected Tropical Diseases Drugs and Vaccine Production Growth Rate (2020-2025)
12.7.2 China Neglected Tropical Diseases Drugs and Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
13 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Type (2020-2033)
13.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2020-2033)
13.4 Global Neglected Tropical Diseases Drugs and Vaccine Price by Type (2020-2033)
14 NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Sales by Application (2020-2033)
14.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2020-2033)
14.4 Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 Artecef BV
15.1.1 Artecef BV Basic Information
15.1.2 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.1.4 Artecef BV Business Overview
15.1.5 Artecef BV SWOT Analysis
15.1.6 Artecef BV Recent Developments
15.2 GlaxoSmithKline
15.2.1 GlaxoSmithKline Basic Information
15.2.2 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.2.4 GlaxoSmithKline Business Overview
15.2.5 GlaxoSmithKline SWOT Analysis
15.2.6 GlaxoSmithKline Recent Developments
15.3 AstraZeneca
15.3.1 AstraZeneca Basic Information
15.3.2 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.3.4 AstraZeneca Business Overview
15.3.5 AstraZeneca SWOT Analysis
15.3.6 AstraZeneca Recent Developments
15.4 Novartis
15.4.1 Novartis Basic Information
15.4.2 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.4.4 Novartis Business Overview
15.4.5 Novartis Recent Developments
15.5 Sanofi-Aventis
15.5.1 Sanofi-Aventis Basic Information
15.5.2 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.5.4 Sanofi-Aventis Business Overview
15.5.5 Sanofi-Aventis Recent Developments
15.6 Ranbaxy Labs
15.6.1 Ranbaxy Labs Basic Information
15.6.2 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.6.4 Ranbaxy Labs Business Overview
15.6.5 Ranbaxy Labs Recent Developments
15.7 Lupin
15.7.1 Lupin Basic Information
15.7.2 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.7.4 Lupin Business Overview
15.7.5 Lupin Recent Developments
15.8 Macleods Pharmaceuticals
15.8.1 Macleods Pharmaceuticals Basic Information
15.8.2 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.8.4 Macleods Pharmaceuticals Business Overview
15.8.5 Macleods Pharmaceuticals Recent Developments
15.9 Cipla
15.9.1 Cipla Basic Information
15.9.2 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.9.4 Cipla Business Overview
15.9.5 Cipla Recent Developments
15.10 Romark Laboratories
15.10.1 Romark Laboratories Basic Information
15.10.2 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.10.4 Romark Laboratories Business Overview
15.10.5 Romark Laboratories Recent Developments
15.11 Toyama Chemica
15.11.1 Toyama Chemica Basic Information
15.11.2 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Overview
15.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
15.11.4 Toyama Chemica Business Overview
15.11.5 Toyama Chemica Recent Developments
16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 4. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (M USD)
Table 5. Neglected Tropical Diseases Drugs and Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2024)
Table 11. Global Market Neglected Tropical Diseases Drugs and Vaccine Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Neglected Tropical Diseases Drugs and Vaccine Manufacturing Sites and Area Served
Table 13. Manufacturers Neglected Tropical Diseases Drugs and Vaccine Product Type
Table 14. Global Neglected Tropical Diseases Drugs and Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Neglected Tropical Diseases Drugs and Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Neglected Tropical Diseases Drugs and Vaccine Market Size Comparison by Region (M USD)
Table 26. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2020-2033) & (M USD)
Table 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Region (2020-2033)
Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region (2020-2033) & (K MT)
Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region (2020-2033)
Table 30. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2033) & (M USD)
Table 31. North America Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2020-2033) & (K MT)
Table 32. North America Neglected Tropical Diseases Drugs and Vaccine Sales by Type (K MT)
Table 33. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 34. North America Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Type (2020-2033)
Table 35. North America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type (2020-2033)
Table 36. North America Neglected Tropical Diseases Drugs and Vaccine Sales by Application (K MT)
Table 37. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (M USD)
Table 38. North America Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Application (2020-2033)
Table 39. North America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2020-2033)
Table 40. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2020-2033) & (K MT)
Table 42. Europe Neglected Tropical Diseases Drugs and Vaccine Sales by Type (K MT)
Table 43. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 44. Europe Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Type (2020-2033)
Table 45. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type (2020-2033)
Table 46. Europe Neglected Tropical Diseases Drugs and Vaccine Sales by Application (K MT)
Table 47. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (M USD)
Table 48. Europe Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Application (2020-2033)
Table 49. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Sales by Type (K MT)
Table 53. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 54. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Sales by Application (K MT)
Table 57. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (M USD)
Table 58. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2020-2025)
Table 60. South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2033) & (M USD)
Table 61. South America Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2020-2033) & (K MT)
Table 62. South America Neglected Tropical Diseases Drugs and Vaccine Sales by Type (K MT)
Table 63. South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 64. South America Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Type (2020-2033)
Table 65. South America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type (2020-2033)
Table 66. South America Neglected Tropical Diseases Drugs and Vaccine Sales by Application (K MT)
Table 67. South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (M USD)
Table 68. South America Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Application (2020-2033)
Table 69. South America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales by Type (K MT)
Table 73. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 74. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales by Application (K MT)
Table 77. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (M USD)
Table 78. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2020-2033)
Table 80. Global Neglected Tropical Diseases Drugs and Vaccine Production (K MT) by Region(2020-2025)
Table 81. Global Neglected Tropical Diseases Drugs and Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Region (2020-2025)
Table 83. Global Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Neglected Tropical Diseases Drugs and Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Type (K MT)
Table 89. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Table 90. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Type (2020-2033)
Table 91. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Type (2020-2033)
Table 92. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type (2020-2033)
Table 93. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Share by Type (2020-2033)
Table 94. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) by Application
Table 95. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application(M USD)
Table 96. Global Neglected Tropical Diseases Drugs and Vaccine Sales by Application (2020-2033) & (K MT)
Table 97. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application (2020-2033)
Table 98. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2020-2033) & (M USD)
Table 99. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2020-2033)
Table 100. Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2020-2033)
Table 101. Artecef BV Basic Information
Table 102. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 103. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Artecef BV Business Overview
Table 105. Artecef BV SWOT Analysis
Table 106. Artecef BV Recent Developments
Table 107. GlaxoSmithKline Basic Information
Table 108. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 109. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. GlaxoSmithKline Business Overview
Table 111. GlaxoSmithKline SWOT Analysis
Table 112. GlaxoSmithKline Recent Developments
Table 113. AstraZeneca Basic Information
Table 114. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 115. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. AstraZeneca Business Overview
Table 117. AstraZeneca SWOT Analysis
Table 118. AstraZeneca Recent Developments
Table 119. Novartis Basic Information
Table 120. Novartis Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 121. Novartis Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Novartis Business Overview
Table 123. Novartis Recent Developments
Table 124. Sanofi-Aventis Basic Information
Table 125. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 126. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Sanofi-Aventis Business Overview
Table 128. Sanofi-Aventis Recent Developments
Table 129. Ranbaxy Labs Basic Information
Table 130. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 131. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Ranbaxy Labs Business Overview
Table 133. Ranbaxy Labs Recent Developments
Table 134. Lupin Basic Information
Table 135. Lupin Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 136. Lupin Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Lupin Business Overview
Table 138. Lupin Recent Developments
Table 139. Macleods Pharmaceuticals Basic Information
Table 140. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 141. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Macleods Pharmaceuticals Business Overview
Table 143. Macleods Pharmaceuticals Recent Developments
Table 144. Cipla Basic Information
Table 145. Cipla Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 146. Cipla Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Cipla Business Overview
Table 148. Cipla Recent Developments
Table 149. Romark Laboratories Basic Information
Table 150. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 151. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Romark Laboratories Business Overview
Table 153. Romark Laboratories Recent Developments
Table 154. Toyama Chemica Basic Information
Table 155. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Overview
Table 156. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Toyama Chemica Business Overview
Table 158. Toyama Chemica Recent Developments
List of Figures
Figure 1. Product Picture of Neglected Tropical Diseases Drugs and Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neglected Tropical Diseases Drugs and Vaccine Product Life Cycle
Figure 13. Neglected Tropical Diseases Drugs and Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Neglected Tropical Diseases Drugs and Vaccine Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Neglected Tropical Diseases Drugs and Vaccine
Figure 19. Global Neglected Tropical Diseases Drugs and Vaccine Market PEST Analysis
Figure 20. Global Neglected Tropical Diseases Drugs and Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region
Figure 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Region (2020-2033)
Figure 28. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Country
Figure 33. USA Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Neglected Tropical Diseases Drugs and Vaccine Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Neglected Tropical Diseases Drugs and Vaccine Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD)by Type
Figure 40. North America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Country
Figure 45. Germany Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type
Figure 56. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Country
Figure 61. China Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type
Figure 72. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Country
Figure 77. Brazil Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type
Figure 84. South America Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Country
Figure 89. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Neglected Tropical Diseases Drugs and Vaccine Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Neglected Tropical Diseases Drugs and Vaccine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Type
Figure 100. Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application
Figure 101. Global Neglected Tropical Diseases Drugs and Vaccine Production Market Share by Region (2020-2025)
Figure 102. North America Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. China Neglected Tropical Diseases Drugs and Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (M USD)
Figure 108. Sales Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type (2020-2033)
Figure 109. Sales Market Share of Neglected Tropical Diseases Drugs and Vaccine by Type in 2024
Figure 110. Market Size Share of Neglected Tropical Diseases Drugs and Vaccine by Type (2020-2033)
Figure 111. Market Size Share of Neglected Tropical Diseases Drugs and Vaccine by Type in 2024
Figure 112. Global Neglected Tropical Diseases Drugs and Vaccine Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application(M USD)
Figure 115. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application
Figure 116. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application (2020-2033)
Figure 117. Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Application in 2024
Figure 118. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application (2020-2033)
Figure 119. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application in 2024
Figure 120. Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2020-2033)
